A share price of Emergent Biosolutions Inc [EBS] is currently trading at $10.65, up 7.68%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EBS shares have gain 34.30% over the last week, with a monthly amount glided 64.35%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Emergent Biosolutions Inc [NYSE: EBS] stock has seen the most recent analyst activity on March 07, 2024, when The Benchmark Company upgraded its rating to a Buy but kept the price target unchanged to $5 for it. On August 29, 2023, downgrade downgraded it’s rating to Hold. The Benchmark Company upgraded its rating to a Buy but stick to its price target of $22 on April 10, 2023. JP Morgan downgraded its rating to a Underweight and reduced its price target to $9 on March 17, 2023. The Benchmark Company downgraded its rating to Hold for this stock on November 10, 2022. In a note dated April 29, 2022, Cantor Fitzgerald downgraded an Neutral rating on this stock.
Emergent Biosolutions Inc experienced fluctuations in its stock price throughout the past year between $1.42 and $10.24. Currently, Wall Street analysts expect the stock to reach $51.5 within the next 12 months. Emergent Biosolutions Inc [NYSE: EBS] shares were valued at $10.65 at the most recent close of the market. An investor can expect a potential return of 383.57% based on the average EBS price forecast.
Analyzing the EBS fundamentals
Trailing Twelve Months sales for Emergent Biosolutions Inc [NYSE:EBS] were 1.19B which represents 81.95% growth. Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -0.45%, Pretax Profit Margin comes in at -0.47%, and Net Profit Margin reading is -0.48%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.77 and Total Capital is -0.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.00 points at the first support level, and at 9.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.13, and for the 2nd resistance point, it is at 11.60.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Emergent Biosolutions Inc [NYSE:EBS] is 1.08. In addition, the Quick Ratio stands at 0.55 and the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 0.47, the price to book ratio is 0.84.
Transactions by insiders
Recent insider trading involved Zoon Kathryn C, Director, that happened on Jun 04 ’24 when 10000.0 shares were sold. Director, Zoon Kathryn C completed a deal on May 29 ’24 to sell 1830.0 shares. Meanwhile, Director Zoon Kathryn C sold 1089.0 shares on May 21 ’24.
